A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2
about
Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patientsProphylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patientsProphylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patientsIdentification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489Cloning, overexpression, and purification of novobiocic acid synthetase from Streptomyces spheroides NCIMB 11891.Guidelines for the prevention of intravascular catheter-related infections.Biological activities of novel gyrase inhibitors of the aminocoumarin classAntimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.Long-term catheterization: current approaches in the diagnosis and treatment of port-related infectionsSynergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents.Heterologous expression of novobiocin and clorobiocin biosynthetic gene clusters.Metabolic engineering of aminocoumarins: inactivation of the methyltransferase gene cloP and generation of new clorobiocin derivatives in a heterologous host.
P2860
Q24202372-59FCE516-D7B4-47AA-B169-6C93AA0B4DEFQ24246346-5414F4E6-9128-4AFB-A10B-29B50128A732Q24250254-45758491-F644-4F1E-ADBB-7A717711BD95Q30944562-29BC35C9-D731-4B4F-932F-039379E2F09DQ31364585-0699A950-3251-4784-A561-D29022EA9427Q34175393-3FECCEBF-2F4B-44B3-BAE0-EB80AFFFFD18Q36702934-B9C388A4-35C4-4451-8D2A-861A76BA37C9Q37120952-7D2075BC-20F6-4D51-A8A7-3BB4CF9C41BEQ37601271-2A6B6836-C170-4E7E-B9B2-2242610CB29DQ40336024-669273D8-3971-4DFE-8C3C-51C51FC9379CQ41932715-E69495BF-C026-42F8-B351-6934DE086A29Q46565627-617EC44B-E194-4E97-8419-AE4A44D57D06
P2860
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A prospective crossover random ...... nts treated with interleukin-2
@ast
A prospective crossover random ...... nts treated with interleukin-2
@en
A prospective crossover random ...... nts treated with interleukin-2
@nl
type
label
A prospective crossover random ...... nts treated with interleukin-2
@ast
A prospective crossover random ...... nts treated with interleukin-2
@en
A prospective crossover random ...... nts treated with interleukin-2
@nl
prefLabel
A prospective crossover random ...... nts treated with interleukin-2
@ast
A prospective crossover random ...... nts treated with interleukin-2
@en
A prospective crossover random ...... nts treated with interleukin-2
@nl
P2093
P2860
P1433
P1476
A prospective crossover random ...... nts treated with interleukin-2
@en
P2093
A C Buzaid
D Abi-Said
K V Rolston
R Y Hachem
P2860
P304
P356
10.1002/(SICI)1097-0142(19980115)82:2<412::AID-CNCR22>3.0.CO;2-0
P407
P577
1998-01-15T00:00:00Z